Letter to the EditorCombined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
Section snippets
Funding sources
This study was supported by grants from the National Health and Medical Research Council of Australia program grant ID 546272. TVL was supported by post-doctoral research grant 2011062 from the South-Eastern Norwegian Health Authority.
Disclosures
HK has research contracts and served as a consultant to Novartis. TvL has received lecture honoraria from Novartis. RW and PJ are Novartis employees and may own Novartis stocks.
Conflict of interest
The other authors report no relevant conflicts of interest.
References (8)
- et al.
Neprilysin inhibitors preserve renal function in heart failure
Int. J. Cardiol.
(Jan 20 2015) - et al.
Worsening renal function during renin–angiotensin–aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction
Eur. J. Heart Fail.
(2014) - et al.
Renin–angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ. Heart Fail.
(2013) - et al.
Angiotensin–neprilysin inhibition versus enalapril in heart failure
N. Engl. J. Med.
(2014)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2015 Published by Elsevier Ireland Ltd.